Go Deep
Organon & Co.
Organon & Co. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 6,457 | 17.7 | 3.60 | 8.50 | 1,333.89 |
| Oct 2026 | 6,472 | 17.7 | 3.60 | 8.50 | 1,318.35 |
| Oct 2026 | 10,723 | 17.7 | 3.60 | 8.50 | 1,311.37 |
| Oct 2026 | 10,738 | 17.6 | 3.59 | 8.50 | 1,304.58 |
| Oct 2026 | 10,728 | 17.6 | 3.59 | 8.50 | 1,306.66 |
| Oct 2026 | 10,728 | 17.6 | 3.59 | 8.50 | 1,303.28 |
| Oct 2026 | 10,733 | 17.6 | 3.59 | 8.50 | 1,303.73 |
| Oct 2026 | 10,728 | 17.6 | 3.59 | 8.50 | 1,304.67 |
| Oct 2026 | 10,733 | 17.6 | 3.59 | 8.50 | 1,300.50 |
| Oct 2026 | 10,733 | 17.6 | 3.59 | 8.50 | 1,297.87 |
Organon & Co. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,558,000,000.0 | 1,460,000,000.0 | 1,507,000,000.0 | 1,602,000,000.0 |
| Net Profit | 108,000,000.0 | 146,000,000.0 | -205,000,000.0 | 160,000,000.0 |
| EPS | 0.4 | 0.6 | -0.8 | 0.6 |
Organon & Co. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 6,216,000,000.0 | 6,403,000,000.0 | 6,263,000,000.0 | 6,174,000,000.0 | — |
| Net Profit | 187,000,000.0 | 864,000,000.0 | 1,023,000,000.0 | 917,000,000.0 | — |
| EPS | 0.7 | 3.4 | 4.0 | 3.6 | — |
Organon & Co. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 12,867,000,000.0 | 13,101,000,000.0 | 12,058,000,000.0 | 10,955,000,000.0 | — |
| Total Liabilities | 12,115,000,000.0 | 12,629,000,000.0 | 12,128,000,000.0 | 11,847,000,000.0 | — |
| Total Equity | 752,000,000.0 | 472,000,000.0 | -70,000,000.0 | -892,000,000.0 | — |
Owes vs Owns
Organon & Co. owed $0.92 for every $1 it owned in Jun 2026, down from $1.08 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.92× | 0.94× | 0.96× | 1.01× | 1.08× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Organon & Co. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 4.5%Receivables 10.3%Inventory 10.9%Fixed assets (tangible) 10.1%Intangible assets 41.1%Other assets 23.1%
How it's funded — Dec 2025
Long-term debt 67.1%Payables 7.4%Other liabilities 19.6%Shareholders' equity 5.8%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 574.0 | 675.0 | 693.0 | 706.0 |
| Receivables | 1,331.0 | 1,358.0 | 1,744.0 | 1,475.0 |
| Inventory | 1,406.0 | 1,321.0 | 1,315.0 | 1,003.0 |
| Fixed assets (tangible) | 1,303.0 | 1,168.0 | 1,183.0 | 1,018.0 |
| Intangible assets | 5,283.0 | 6,094.0 | 5,136.0 | 5,252.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 2,970.0 | 2,485.0 | 1,987.0 | 1,501.0 |
| Liabilities & equity | ||||
| Short-term debt | 16.0 | 20.0 | 9.0 | 8.0 |
| Long-term debt | 8,628.0 | 8,860.0 | 8,751.0 | 8,905.0 |
| Payables | 952.0 | 1,153.0 | 1,314.0 | 1,132.0 |
| Other liabilities | 2,519.0 | 2,596.0 | 2,054.0 | 1,802.0 |
| Shareholders' equity | 752.0 | 472.0 | -70.0 | -892.0 |
| Net tangible assets | -4,531.0 | -5,622.0 | -5,206.0 | -6,144.0 |
Organon & Co. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 700,000,000.0 | 939,000,000.0 | 799,000,000.0 | 858,000,000.0 | — |
| Investing Activities | -390,000,000.0 | -513,000,000.0 | -260,000,000.0 | -420,000,000.0 | — |
| Financing Activities | -561,000,000.0 | -368,000,000.0 | -569,000,000.0 | -433,000,000.0 | — |